Phytonutrients in complex diet therapy for alcoholic liver disease and non-alcoholic fatty liver disease-Reference-Cited by-同舟云学术

Phytonutrients in complex diet therapy for alcoholic liver disease and non-alcoholic fatty liver disease

Published:2024-09-05 Issue:16 Volume: Page:13-18
ISSN:2949-2807
Container-title:Medical alphabet
language:
Short-container-title:Medicinskij alfavit

Author:

Orlova S. V.¹^ORCID,Vodolazkaya A. N.²^ORCID,Tarasova O. I.³^ORCID,Nikitina E. A.⁴^ORCID,Prokopenko E. V.⁵^ORCID,Balashova N. V.⁶^ORCID,Minosyan I. S.³^ORCID,Urazov V. V.³

Affiliation:

1. Peoples’ Friendship University of Russia n. a. Patrice Lumumba (RUDN University); Scientific and Practical Center for Pediatric Psychoneurology of the Moscow Department of Healt

2. Moscow Regional Research Clinical Institute named after M. F. Vladimirsky

3. Peoples’ Friendship University of Russia n. a. Patrice Lumumba (RUDN University)

4. Peoples’ Friendship University of Russia n. a. Patrice Lumumba (RUDN University); Scientific and Practical Center for Pediatric Psychoneurology of the Moscow Department of Healt; National Medical Research Center for Therapy and Preventive Medicine

5. “INVITRO” Limited Liability Company

6. Peoples’ Friendship University of Russia n. a. Patrice Lumumba (RUDN University); Moscow Regional Research Clinical Institute named after M. F. Vladimirsky

Abstract

Alcoholic liver disease (ALD) and non-alcoholic fatty liver disease (NAFLD) are serious health problems with different epidemiological profiles. The long-term goal of treating chronic hepatosis is to prevent the progression of cirrhosis and/or liver cancer and prolong survival and patient’s quality of life. Herbal supplements containing medicinal plants, such as milk thistle, triphala, ginger and plants of the genus Phyllanthus, have great potential in optimizing the therapeutic effect in such patients.

Publisher

Alfmed LLC

Reference74 articles.

1. Jichitu A., Bungau S., Stanescu A. M.A., Vesca C. M., Toma M. M., Bustea C., et al. Non-Alcoholic Fatty Liver Disease and Cardiovascular Comorbidities: Pathophysiological Links, Diagnosis, and Therapeutic Management. Diagnostics (Basel). 2021; 11 (4): 689. DOI: 10.3390/diagnostics11040689

2. Ivashkin V. T., Mayevskaya M. V., Pavlov Ch.S., Tikhonov I. N., Shirokova E. N., Bueverov A. O. et al. Clinical guidelines for the diagnosis and treatment of non-alcoholic fatty liver disease of the Russian Society for the Study of the Liver and the Russian Gastroenterological Association. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2016; 26 (2): 24–42. (In Russ.). DOI: 10.22416/1382-4376-2016-26-2-24-42

3. Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011; 34: 274–285.

4. Maev IV, Abdurakhmanov DT, Andreev DN, Dicheva DT. Alcoholic liver disease: State-of-the-art. Terapevticheskii Arkhiv (Ter. Arkh.). 2014; 86 (4): 108–16.

5. Aslam A, Kwo PY. Epidemiology and Disease Burden of Alcohol Associated Liver Disease. J. Clin Exp Hepatol. 2023; 13 (1): 8802. https://doi.org/10.1016/j.jceh.2022.09.001